Withdrawn
Durability of SARS-CoV-2 Antibodies from Natural Infection in Children and Adolescents
View ORCID ProfileSarah E. Messiah, Frances Brito, Harold W. Kohl III, Stacia DeSantis, Melissa Valerio-Shewmaker, Jessica Ross, Michael D. Swartz, Ashraf Yaseen, Steven H. Kelder, Shiming Zhang, Onyinye S Omega-Njemnobi, Michael O. Gonzalez, Leqing Wu, Eric Boerwinkle, David Lakey, Jennifer A. Shuford, Stephen J. Pont
doi: https://doi.org/10.1101/2021.11.21.21266484
Sarah E. Messiah
aThe University of Texas Health Science Center at Houston, School of Public Health in Dallas, Dallas, TX, USA
bCenter for Pediatric Population Health, The University of Texas Health Science Center at Houston, School of Public Health and Children’s Health System of Texas, Dallas, TX, USA
PhD, MPHFrances Brito
cThe University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, USA
MSHarold W. Kohl III
dThe University of Texas Health Science Center at Houston, School of Public Health in Austin, Austin, TX, USA
eUniversity of Texas at Austin, Austin, TX, USA
PhD, MSPHStacia DeSantis
cThe University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, USA
PhDMelissa Valerio-Shewmaker
fThe University of Texas Health Science Center at Houston, School of Public Health in Brownsville, Brownsville, TX, USA
PhDJessica Ross
cThe University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, USA
BSMichael D. Swartz
cThe University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, USA
PhDAshraf Yaseen
cThe University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, USA
PhDSteven H. Kelder
dThe University of Texas Health Science Center at Houston, School of Public Health in Austin, Austin, TX, USA
PhD, MPHShiming Zhang
cThe University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, USA
MSOnyinye S Omega-Njemnobi
dThe University of Texas Health Science Center at Houston, School of Public Health in Austin, Austin, TX, USA
MD, PhDMichael O. Gonzalez
cThe University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, USA
MPHLeqing Wu
cThe University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, USA
MSEric Boerwinkle
cThe University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, USA
PhDDavid Lakey
gThe University of Texas System, Austin, TX, USA
MDJennifer A. Shuford
hTexas Department of State Health Services, Austin, TX, USA
MDStephen J. Pont
hTexas Department of State Health Services, Austin, TX, USA
MDArticle Information
History
- February 16, 2022.
Article Versions
- Version 1 (November 24, 2021 - 18:25).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Posted February 16, 2022.
Durability of SARS-CoV-2 Antibodies from Natural Infection in Children and Adolescents
Sarah E. Messiah, Frances Brito, Harold W. Kohl III, Stacia DeSantis, Melissa Valerio-Shewmaker, Jessica Ross, Michael D. Swartz, Ashraf Yaseen, Steven H. Kelder, Shiming Zhang, Onyinye S Omega-Njemnobi, Michael O. Gonzalez, Leqing Wu, Eric Boerwinkle, David Lakey, Jennifer A. Shuford, Stephen J. Pont
medRxiv 2021.11.21.21266484; doi: https://doi.org/10.1101/2021.11.21.21266484
Durability of SARS-CoV-2 Antibodies from Natural Infection in Children and Adolescents
Sarah E. Messiah, Frances Brito, Harold W. Kohl III, Stacia DeSantis, Melissa Valerio-Shewmaker, Jessica Ross, Michael D. Swartz, Ashraf Yaseen, Steven H. Kelder, Shiming Zhang, Onyinye S Omega-Njemnobi, Michael O. Gonzalez, Leqing Wu, Eric Boerwinkle, David Lakey, Jennifer A. Shuford, Stephen J. Pont
medRxiv 2021.11.21.21266484; doi: https://doi.org/10.1101/2021.11.21.21266484
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2918)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12711)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4567)
- Geriatric Medicine (415)
- Health Economics (726)
- Health Informatics (2913)
- Health Policy (1068)
- Hematology (386)
- HIV/AIDS (922)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (467)
- Neurology (4335)
- Nursing (234)
- Nutrition (636)
- Oncology (2261)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (499)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6916)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (436)
- Sports Medicine (383)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (178)